The Trend Is Your Friend: Direct Oral Antagonists as Standard Anticoagulants for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Interventions

被引：0
|
作者：
Nordbeck, Peter [1 ,2 ]
Hu, Kai [1 ,2 ]
机构：
[1] Univ Hosp Wurzburg, Dept Internal Med 1, Wurzburg, Germany
[2] Comprehens Heart Failure Ctr, Wurzburg, Germany
来源：
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 2021年 / 77卷 / 02期
关键词：
DABIGATRAN;
D O I：
10.1097/FJC.0000000000000950
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：162 / 163
页数：2
相关论文
共 50 条
  • [31] Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Renal Dysfunction
    Kobalava, Z. D.
    Shavarov, A. A.
    Vatsik-Gorodetskaya, M. V.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2021, 17 (01) : 62 - 72
  • [32] Could direct oral anticoagulants be an alternative to vitamin K antagonists in patients with hypertrophic cardiomyopathy and atrial fibrillation?
    Li, Biao
    Sun, Chao
    Qin, Fen
    Liu, Na
    Wu, Zhihong
    Liu, Qiming
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 256 : 39 - 39
  • [33] Safety of direct oral anticoagulants and vitamin k antagonists in patients with atrial fibrillation and gastrointestinal or urological cancer
    Ording, A. G.
    Sogaard, M.
    Skjoth, F.
    Grove, E. L.
    Larsen, T. B.
    Nielsen, P. B.
    THROMBOSIS RESEARCH, 2021, 200 : S73 - S74
  • [34] The serum metabolomic profiles of atrial fibrillation patients treated with direct oral anticoagulants or vitamin K antagonists
    Vignoli, Alessia
    Gori, Anna Maria
    Berteotti, Martina
    Cesari, Francesca
    Giusti, Betti
    Bertelli, Alessia
    Kura, Ada
    Sticchi, Elena
    Salvadori, Emilia
    Barbato, Carmen
    Formelli, Benedetta
    Pescini, Francesca
    Marcucci, Rossella
    Tenori, Leonardo
    Poggesi, Anna
    LIFE SCIENCES, 2024, 351
  • [35] Perioperative interruption of direct oral anticoagulants and vitamin K antagonists in patients with atrial fibrillation: A comparative analysis
    Shaw, Joseph R.
    Zhang, Tinghua
    Le Gal, Gregoire
    Douketis, James
    Carrier, Marc
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2020, 4 (01) : 131 - 140
  • [36] Antithrombotic treatment in atrial fibrillation patients undergoing percutaneous coronary interventions: focus on stent thrombosis
    Vitolo, Marco
    Javed, Saad
    Capodanno, Davide
    Rubboli, Andrea
    Boriani, Giuseppe
    Lip, Gregory Y. H.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2020, 18 (09) : 587 - 600
  • [37] Triple troubles selecting optimal therapy for atrial fibrillation patients undergoing percutaneous coronary interventions
    Parodi, Guido
    Scudiero, Fernando
    Postepy w Kardiologii Interwencyjnej, 2016, 12 (04): : 287 - 289
  • [38] Safety of new oral anticoagulants for patients undergoing atrial fibrillation ablation
    Gevorg Stepanyan
    Nitish Badhwar
    Randall J. Lee
    Gregory M. Marcus
    Byron K. Lee
    Zian H. Tseng
    Vasanth Vedantham
    Jeffrey Olgin
    Melvin Scheinman
    Edward P. Gerstenfeld
    Journal of Interventional Cardiac Electrophysiology, 2014, 40 : 33 - 38
  • [39] Safety of new oral anticoagulants for patients undergoing atrial fibrillation ablation
    Stepanyan, Gevorg
    Badhwar, Nitish
    Lee, Randall J.
    Marcus, Gregory M.
    Lee, Byron K.
    Tseng, Zian H.
    Vedantham, Vasanth
    Olgin, Jeffrey
    Scheinman, Melvin
    Gerstenfeld, Edward P.
    JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2014, 40 (01) : 33 - 38
  • [40] Interrupted or Uninterrupted Oral Anticoagulants in Patients Undergoing Atrial Fibrillation Ablation
    Yang, Pingping
    Wang, Chenxi
    Ye, Yinquan
    Huang, Tieqiu
    Yang, Shuai
    Shen, Wen
    Xu, Gaosi
    Wu, Qinghua
    CARDIOVASCULAR DRUGS AND THERAPY, 2020, 34 (03) : 371 - 381
12345